Evidence map›Paper›PMID 33763631›Full record

ArticleJAMIA open2021

Designing and evaluating contextualized drug-drug interaction algorithms.

Eric Chou, Richard D Boyce, Baran Balkan, Vignesh Subbian, Andrew Romero, Philip D Hansten, John R Horn, Sheila Gephart, Daniel C Malone

Abstract read
In one paragraph

Article in JAMIA open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Improving the specificity of drug-drug interaction alerts: Can it be done?American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2022
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eric ChouDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Richard D BoyceDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-2993-2085
Baran BalkanCollege of Engineering, University of Arizona, Tucson, Arizona, USA.
Vignesh SubbianCollege of Engineering, University of Arizona, Tucson, Arizona, USA.ORCID https://orcid.org/0000-0001-9974-8382
Andrew RomeroBanner University Medical Center, Tucson, Arizona, USA.
Philip D HanstenDepartment of Pharmacy, University of Washington, Seattle, Washington, USA.
John R HornDepartment of Pharmacy, University of Washington, Seattle, Washington, USA.
Sheila GephartCollege of Nursing, University of Arizona, Tucson, Arizona, USA.
Daniel C MaloneDepartment of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA.

Funding

AHRQ HHS R01 HS025984AHRQ HHS R21 HS023826
6 · The paper itself

Abstract

objectiveAlert fatigue is a common issue with off-the-shelf clinical decision support. Most warnings for drug-drug interactions (DDIs) are overridden or ignored, likely because they lack relevance to the patient's clinical situation. Existing alerting systems for DDIs are often simplistic in nature or do not take the specific patient context into consideration, leading to overly sensitive alerts. The objective of this study is to develop, validate, and test DDI alert algorithms that take advantage of patient context available in electronic health records (EHRs) data.

methodsData on the rate at which DDI alerts were triggered but for which no action was taken over a 3-month period (override rates) from a single tertiary care facility were used to identify DDIs that were considered a high-priority for contextualized alerting. A panel of DDI experts developed algorithms that incorporate drug and patient characteristics that affect the relevance of such warnings. The algorithms were then implemented as computable artifacts, validated using a synthetic health records data, and tested over retrospective data from a single urban hospital.

resultsAlgorithms and computable knowledge artifacts were developed and validated for a total of 8 high priority DDIs. Testing on retrospective real-world data showed the potential for the algorithms to reduce alerts that interrupt clinician workflow by more than 50%. Two algorithms (citalopram/QT interval prolonging agents, and fluconazole/opioid) showed potential to filter nearly all interruptive alerts for these combinations.

conclusionThe 8 DDI algorithms are a step toward addressing a critical need for DDI alerts that are more specific to patient context than current commercial alerting systems. Data commonly available in EHRs can improve DDI alert specificity.

Indexed as

clinicaldecision support systemsdrug interactionknowledge bases

Identifiers

PMID33763631
PMCPMC7976224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.